Member Info for Irontaz

There are far more pressing issues to be concerned about than companies moving.

EW certainly needs to get her priorities in the correct order.

Talks with Ofgem underway. Sky News

https://finance.yahoo.com/news/activist-elliott-presses-gsk-progress-003755576.html

Malta is slowly coming online. MGC have made arrangements in the interim for production in Germany and USA.

Stock up on Day Nurse and Night Nurse, or even ArtemiC!

With the next ex-dividend on Thursday 18th November 2021 of 19p a share, may well see a rise between now and then.

Next one is Thursday 18 November  2021, payable on Thursday 13 January 2022, that's for Q3. 19p a share.

Thursday 19 August  2021

Has everyone's Dividend landed safely today ?

https://www.thisismoney.co.uk/money/share-investing/article-10052825/STOCKS-WATCH-New-GSK-invest-8bn-war-chest.html

New placing was over subscribed. Raising it from £200m to £275m. New Shares start trading today.

£150 entry ticket !

They will pay the 80p Dividend (3 x 19p, 1 x 23p) for 2021 by April 2022.

They have indicated that the new Dividend will be 55p between the two new companies for 2022 onwards.

The status quo at the top won't see it as beneficial unless they are in on the deal. Unfortunately that's the way of the world. It's all about 'favours' and envelopes filled with cash. You scratch my back and I'll scratch yours...

Plus what sort of numbers do we expect at the end of this 1st Quarter which is fast approaching.

There is plenty to talk about...

Health Canada, US, India and Germany & EU, ArtemiC sales take your pick....

RNS is coming, just be patient.

Very confident statement.

After the http add that's the missing bit

*********************/

Go on London Stock Exchange website and see the report from proactive on MGC.

MGC Pharmaceuticals - Rapid progress

"At the current global infection rate of 600k new COVID infections per day, if 5% of patients received CimetrA this would equate to US$3m per day of revenue."

https://*********************/companies/australia/mgc-pharmaceuticals-ltd-/research/proactive/mgc-pharmaceuticals-rapid-progress/24_d03f919e-d5e2-41c2-a6a8-0efeae6f55fe?partner=lse